Healthcare
Live Price
Offline$0.0219
+0.00% today
1Y Change
-56.20%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 246 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
TripSitter Clinic Ltd. (TSTTF) is a Healthcare stock with listed on OTC. The stock last traded around $0.02 and down 56.2% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +69.6%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +69.6%, free cash flow +76.9% with operating margin 0.0% and ROIC 32.0%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TSTTF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TSTTF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TSTTF Max Drawdown
-78.27%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TSTTF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
-100.0% YoY
FY Net Income
-$179.3K
+98.2% YoY
Free Cash Flow
-$93.0K
+94.7% YoY
Revenue Growth
-100.0%
EPS Growth
+69.6%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 14K | 488K | 87K | 0 |
| Gross Profit | 0 | 14K | 139K | -555K | 0 |
| Operating Income | -142K | -348K | -2M | -2M | -178K |
| EBITDA | -10K | -348K | -2M | -2M | -178K |
| Net Income | -10K | -305K | -2M | -10M | -179K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1K | 3K | 55K | 1M | 772K |
| Total Assets | 1K | 3K | 99K | 1M | 781K |
| Total Liabilities | 749K | 731K | 549K | 198K | 93K |
| Shareholder Equity | -747K | -728K | -450K | 1M | 687K |
| Total Debt | 340K | 273K | 134K | 134K | 18K |
| Net Debt | 338K | 270K | 79K | -1M | -755K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
93K
+94.7% YoY
Capital Expenditures
0
Free Cash Flow
93K
+94.7% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.6%
Debt / Equity
-0.48x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.